Exagen Inc.
XGN- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001274737
In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Exagen Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 38 | 53 | +15 |
| Shares | 6.24M | 9.16M | +2.92M (+46.9%) |
| Value | $22.4M | $63.9M | +$41.5M (+185.4%) |
New holders (22)
Institutions that held Exagen Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 718,782 | $5.02M | 0.01% |
| Wexford Capital LP | 416,348 | $2.91M | 0.81% |
| Russell Investments Group, Ltd. | 220,616 | $1.54M | 0.00% |
| FourWorld Capital Management LLC | 208,527 | $1.46M | 1.05% |
| Manatuck Hill Partners, LLC | 175,000 | $1.22M | 0.46% |
| Point72 Asset Management, L.P. | 136,380 | $951.9K | 0.00% |
| Mink Brook Asset Management LLC | 130,000 | $907.4K | 0.79% |
| EAM Investors, LLC | 97,773 | $682.5K | 0.10% |
| Ameriprise Financial Inc | 94,953 | $662.8K | 0.00% |
| Calamos Advisors LLC | 75,413 | $526.4K | 0.00% |
| Citizens Financial Group Inc | 67,600 | $471.8K | 0.01% |
| Two Sigma Investments, LP | 63,000 | $439.7K | 0.00% |
| B. Riley Financial, Inc. | 50,000 | $349.0K | 0.39% |
| Quadrature Capital Ltd | 31,055 | $216.8K | 0.00% |
| Goldman Sachs Group Inc | 22,602 | $157.8K | 0.00% |
| Occudo Quantitative Strategies LP | 19,808 | $138.3K | 0.02% |
| XTX Topco Ltd | 19,033 | $132.8K | 0.01% |
| Virtu Financial LLC | 10,039 | $70.0K | 0.00% |
| Truvestments Capital LLC | 2,471 | $17.2K | 0.00% |
| Raymond James Financial Inc | 1,568 | $10.9K | 0.00% |
| Lazard Asset Management LLC | 1,200 | $8.00K | 0.00% |
| FMR LLC | 357 | $2.49K | 0.00% |
Sold out (7)
Institutions that held Exagen Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Hudson Bay Capital Management LP | 166,705 | $598.5K |
| Marshall Wace, LLP | 106,559 | $382.5K |
| Stonepine Capital Management, LLC | 95,747 | $343.7K |
| Prudential Financial Inc | 16,200 | $58.2K |
| Gsa Capital Partners LLP | 12,287 | $44.0K |
| Citadel Advisors LLC | 4,284 | $15.4K |
| Tower Research Capital LLC (TRC) | 62 | $223 |